Zealand ac­quires a strug­gling di­a­betes med-tech in push in­to US mar­ket

Zealand Phar­ma is ex­pand­ing again.

Four months af­ter buy­ing out Cana­da’s En­cy­cle Ther­a­peu­tics and their li­brary of GI-drug­ging pep­tides, Zealand has agreed to pur­chase …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.